Canada markets open in 1 hour 26 minutes

Tenax Therapeutics, Inc. (TENX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.8400-0.0200 (-0.52%)
At close: 04:00PM EDT
3.8400 0.00 (0.00%)
Pre-Market: 08:00AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.52M
Enterprise Value -1.77M
Trailing P/E N/A
Forward P/E 0.30
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.93
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.23

Trading Information

Stock Price History

Beta (5Y Monthly) 2.27
52-Week Change 3-85.38%
S&P500 52-Week Change 322.38%
52 Week High 361.2000
52 Week Low 33.4700
50-Day Moving Average 33.9157
200-Day Moving Average 316.9460

Share Statistics

Avg Vol (3 month) 3210k
Avg Vol (10 day) 345.11k
Shares Outstanding 51.96M
Implied Shares Outstanding 61.96M
Float 81.84M
% Held by Insiders 10.35%
% Held by Institutions 14.08%
Shares Short (Apr 15, 2024) 435.2k
Short Ratio (Apr 15, 2024) 40.66
Short % of Float (Apr 15, 2024) 41.80%
Short % of Shares Outstanding (Apr 15, 2024) 41.80%
Shares Short (prior month Mar 15, 2024) 436.72k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 26, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:80
Last Split Date 3Jan 03, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-68.21%
Return on Equity (ttm)-160.79%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -8.23M
Net Income Avi to Common (ttm)-7.71M
Diluted EPS (ttm)-31.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.79M
Total Cash Per Share (mrq)5
Total Debt (mrq)500.9k
Total Debt/Equity (mrq)6.19%
Current Ratio (mrq)3.26
Book Value Per Share (mrq)27.15

Cash Flow Statement

Operating Cash Flow (ttm)-5.9M
Levered Free Cash Flow (ttm)-3.79M